Neo Ivy Capital Management - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2023$296
-94.1%
2,094
+5269.2%
0.16%
+2500.0%
Q3 2021$5,000
-91.2%
39
-86.6%
0.01%
-90.3%
Q1 2021$57,000
+1040.0%
291
+646.2%
0.06%
+3000.0%
Q2 2020$5,000
-96.4%
39
-97.3%
0.00%
-99.1%
Q1 2020$139,000
-61.4%
1,435
-79.0%
0.23%
-20.1%
Q4 2018$360,0006,8310.28%
Other shareholders
REPLIGEN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,102,383$211,250,0009.08%
Ranger Investment Management 339,771$65,110,0003.43%
Pinz Capital Management, LP 36,400$6,975,0003.17%
Conestoga Capital Advisors, LLC 1,021,918$195,830,0003.12%
Ally Bridge Group (NY) LLC 82,500$15,809,0002.71%
AWM Investment Company, Inc. 100,000$19,163,0002.44%
Nicholas Investment Partners, LP 130,491$25,006,0001.93%
BBR PARTNERS, LLC 120,221$23,038,0001.91%
FRIESS ASSOCIATES LLC 129,430$24,803,0001.83%
Stephens Investment Management Group LLC 628,456$120,431,0001.79%
View complete list of REPLIGEN CORP shareholders